15-022
Showing 1 - 25 of >10,000
SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza
Active, not recruiting
- SARS-CoV-2 Infection
- COVID-19
- SARS-CoV-2 rS/Matrix M1-Adjuvant
- +2 more
-
Belfast, Antrim, United Kingdom
- +32 more
Oct 19, 2022
Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022
Not yet recruiting
- Cancer
- Relapsed/Refractory Large B-cell Lymphoma (LBCL)
- Fludarabine (30 mg/m^2)
- +2 more
- (no location specified)
Jul 25, 2023
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)
Completed
- Pneumococcal Infections
- V114
- +2 more
-
Palo Alto, California
- +51 more
Sep 23, 2022
Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Recruiting
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Phoenix, Arizona
- +4 more
Sep 8, 2022
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +10 more
Mar 21, 2022
Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)
Active, not recruiting
- Spondylitis, Ankylosing
- CC-99677
- Placebo
-
Flagstaff, Arizona
- +139 more
Dec 9, 2022
Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (ICP-022, Chlorambucil, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- ICP-022
- +2 more
-
Bengbu, Anhui, China
- +55 more
Mar 25, 2022
Herpes Zoster Trial in Tartu (HZ/su vaccine)
Recruiting
- Herpes Zoster
- HZ/su vaccine
-
Elkridge, Maryland
- +47 more
Jan 6, 2023
Wounds and Injuries, Lacerations, Surgical Incision Trial in Worldwide (MAR-CUTIS, Dermabond Advanced)
Terminated
- Wounds and Injuries
- +2 more
- MAR-CUTIS
- Dermabond Advanced
-
Amiens, France
- +18 more
Aug 10, 2020
Obese, Weight, Body Trial in Paterna (Probiotic)
Not yet recruiting
- Obese
- Weight, Body
- Probiotic
-
Paterna, Valencia, SpainInstitute of Agrochemistry and Food Technology
May 25, 2023
Migraine Disorders Trial (Rizatriptan 5 mg, Rizatriptan 10 mg, Standard Care)
Completed
- Migraine Disorders
- Rizatriptan 5 mg
- +2 more
- (no location specified)
Feb 1, 2022
Migraine Headache Trial (rizatriptan benzoate (MK0462), Comparator: )
Completed
- Migraine Headache
- rizatriptan benzoate (MK0462)
- Comparator: placebo
- (no location specified)
Feb 1, 2022
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
Alcohol Abuse Alcoholism, General Practice, Screening and Brief Intervention Trial in Odense C (The 15-Method)
Active, not recruiting
- Alcohol Abuse Alcoholism
- +2 more
- The 15-Method
-
Odense C, Fynen, DenmarkUnit for Clinical Alcohol Research, Clinical Institute, Universi
Jun 22, 2023
Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)
Not yet recruiting
- Advanced/Metastatic Solid Tumors
-
Adelaide, Australia
- +3 more
Jan 30, 2023
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Enrolling by invitation
- Diabetic Macular Edema
- Diabetic Retinopathy
- ADVM-022
-
Beverly Hills, California
- +6 more
Nov 4, 2022
Cancer Diagnosis, LungCancer, Gastric Cancer Trial in China
Not yet recruiting
- Cancer Diagnosis
- +7 more
-
Guangzhou, Guangdong, China
- +6 more
Sep 18, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Monalizumab, Cetuximab)
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
-
Tucson, Arizona
- +126 more
Oct 21, 2022
Spinal Cord Injuries Trial in Columbia (Adaptive Rowing Exercise)
Recruiting
- Spinal Cord Injuries
- Adaptive Rowing Exercise
-
Columbia, South CarolinaPublic Health Research Center
Jul 24, 2023